RitoDex Eye Drops

Adult dosage

Instill 1-2 drops into the conjunctival sac every 4-6 hours. For the initial 24-48 hours, instill 1-2 drops every 2 hours, and as symptoms improve, gradually reduce the dosage but do not stop administration prematurely.

This drug should not be used in patients with simple herpes keratitis of the epithelium, vaccinia, varicella, and viral diseases of the cornea and conjunctiva, ocular tuberculosis, or fungal infections of the eye. Additionally, it is not safe to administer this medication to patients who have allergic reactions to it, to children, or to breastfeeding women. Local side effects such as itching or swelling of the eyelids, conjunctival redness may occur; rare but serious side effects include optic nerve damage, glaucoma, and vision impairment. When using this drug together with other systemic aminoglycoside antibiotics, careful monitoring of blood concentrations is necessary, and administration should be stopped immediately if adverse reactions occur. In cases of acute purulent infection of the eye, it is important to note that the steroid components may worsen or mask the infection. Long-term use may lead to fungal infections of the cornea; thus, if corneal ulcers persist after treatment, the possibility of fungal infection should be considered, and secondary bacterial infections may occur due to immune suppression. Overuse may result in punctate keratitis, erythema, eyelid itching, and increased tearing, and, in rare cases, blurred vision. Prolonged use can lead to an increase in fungi or resistant pathogens, requiring caution, and cross-resistance with other aminoglycoside antibiotics may occur. Adequate treatment should be received during reinfection. In particular, if infected with varicella or measles during the use of this drug, it can have serious consequences, so the patient's history of varicella or measles and vaccination status should be checked before administration, and if infection is suspected or occurs, medical attention should be sought immediately. The safety of this drug during pregnancy has not been established; therefore, it should only be used by pregnant women or those who could become pregnant if the benefits outweigh the risks. The safety and efficacy in pediatric patients have not been sufficiently established. This drug is for ophthalmic use only and should not be injected into the eye. Care should be taken to avoid direct contact between the container opening and the eye during administration, and it is advisable not to share the product to prevent contamination. When storing, keep it out of reach of children, avoid direct sunlight, and store in a cool, dry place. Additionally, to avoid misuse and maintain quality, do not transfer to another container.

Serious side effects

• Optic nerve damage
• vision and field impairment
• cataract formation
• perforation of the eye
• delayed wound healing
• hypersensitivity
• fungal infections of the cornea
• secondary bacterial infections.

Mild side effects

• Eyelid itching and swelling
• conjunctival redness
• punctate keratitis
• erythema
• increased tearing
• blurred vision.

This drug is sensitive to air and moisture and must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

A colorless, translucent ophthalmic solution in a white suspension contained in a plastic bottle.

Package unit

6mL/bottle